1. Academic Validation
  2. Antiplatelet aggregation constituents from Annona purpurea

Antiplatelet aggregation constituents from Annona purpurea

  • J Nat Prod. 1998 Dec;61(12):1457-61. doi: 10.1021/np9800046.
F R Chang 1 J L Wei C M Teng Y C Wu
Affiliations

Affiliation

  • 1 Graduate Institute of Natural Products, Kaohsiung Medical College, Kaohsiung, Taiwan, Republic of China, and Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China.
Abstract

Bioactivity-directed fractionation led to the isolation of 19 compounds, including three oxoaporphines, oxopurpureine (5), oxonuciferine (6), and oxoglaucine (7); three aporphines, (+)-predicentrine (8), (-)-glaucine (9), and thalbaicalidine (10); one aporphine sensu stricto, N-formyl-purpureine (11); one proaporphine, glaziovine; one phenanthrene, thalicpureine (12); two 6a,7-dehydroaporphines, dehydrolirinidine (13) and 7-hydroxy-dehydroglaucine (14); four Flavonoids, quercetin-3-O-rhamnoside, kaempferol-3-O-rhamnoside, isorhamnetin-3-O-rhamnoside, and tanarixetin-3-O-rhamnoside; one purine, adenine; one lactam amide, squamolone; and two Steroids, beta-sitosterol and beta-sitosterol-beta-D-glucoside from the MeOH extract of the leaves of Formosan Annona purpurea. Among them, 11-14 were characterized as new compounds and Alkaloids, 5-8, 10, and 12-14 exhibited significant antiplatelet aggregation activity.

Figures
Products